Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar outsidernone (< 20) Submitted: 12/1/2010 3:02:15 PM : Outperform Start Price: $26.97 VRX Score: +70.67

Approval of new drug

Featured Broker Partners


Advertisement